Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Ludwig Oxford research is helping to combat this devastating disease.

Unfortunately, only 15% patients diagnosed with oesophageal cancer survive 5 years. Part of the reason for the high mortality is the frequently late detection of this cancer, making current treatments less effective. At Ludwig Oxford, we are researching both new early detection methods and new treatment combinations to improve the outcomes of patients with this disease. The CRUK Oxford Centre have highlighted our research in their recent blogs about researchers Tom Carroll, Richard Owen and Barbara Braden.